Reducing Toxicity, Improving Efficacy: Companion Diagnostics for Targeted Oncology Therapies Show Lower Adverse Event Rates in Clinical Trials.
Beyond simply identifying patients who will respond to a targeted therapy, companion diagnostics play a crucial, but often overlooked, role in patient safety. By accurately stratifying patient populations, CDx can help physicians avoid prescribing powerful drugs to individuals who are genetically predisposed to experiencing severe adverse reactions, thereby significantly improving the safety...
0 Comentários 0 Compartilhamentos 279 Visualizações 0 Anterior